Skip to main content

Role of Insulin in Reducing Mortality in the Perioperative Period

  • Chapter
  • First Online:
Reducing Mortality in the Perioperative Period

Abstract

Hyperglycaemia is a frequently diagnosed metabolic abnormality in the inpatient setting, either related to the case of known diabetes, previously undiagnosed diabetes or as a result of the acute or exacerbation of presenting chronic illness [1, 2]. Stress hyperglycaemia may also be induced by medications including steroids, inotropic agents, immunosuppressants and nutritional support via the enteral or parenteral route [1, 2]. Preoperative glycaemic imbalance and perioperative elevations of blood glucose are directly associated with poor prognosis [1–4], including increase in mortality, decrease in cardiovascular event-free survival, increase in resource utilisation and decrease in quality of life. Hyperglycaemia significantly influences hospital morbidity, including increase in the risk of infections, renal failure, prolonged mechanical ventilation and anaemia requiring blood transfusions, which subsequently extends the length of hospital stay [1–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pichardo-Lowden A, Gabbay RA (2012) Management of hyperglycemia during the perioperative period. Curr Diab Rep 12:108–118

    Article  CAS  PubMed  Google Scholar 

  2. Wang CC, Reusch JE (2012) Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol 110:58B–68B

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kwon S, Thompson R, Dellinger P et al (2013) Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg 257:8–14

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sato H, Carvalho G, Sato T et al (2010) The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J Clin Endocrinol Metab 95:4338–4344

    Article  CAS  PubMed  Google Scholar 

  5. Landoni G, Augoustides JG, Guarracino F et al (2011) Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensiv Care Cardiovasc Anesth 3:9–19

    CAS  Google Scholar 

  6. Landoni G, Rodseth RN, Santini F et al (2012) Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth 26:764–772

    Article  PubMed  Google Scholar 

  7. Landoni G, Pisano A, Lomivorotov V et al (2016) Randomized evidence for reduction of perioperative mortality: an updated consensus process. J Cardiothorac Vasc Anesth doi:10.1053/j.jvca.2016.07.017

  8. Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367

    Article  PubMed  Google Scholar 

  9. Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461

    Article  PubMed  Google Scholar 

  10. Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300:933–944

    Article  CAS  PubMed  Google Scholar 

  11. Kansagara D, Fu R, Freeman M et al (2011) Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 154:268–282

    Article  PubMed  Google Scholar 

  12. Sathya B, Davis R, Taveira T, Whitlatch H, Wu WC (2013) Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract 102:8–15

    Article  CAS  PubMed  Google Scholar 

  13. NICE-SUGAR Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297

    Article  Google Scholar 

  14. NICE-SUGAR Study Investigators, Finfer S, Liu B et al (2012) Hypoglycemia and risk of death in critically ill patients. N Engl J Med 20:1108–1118

    Article  Google Scholar 

  15. Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139

    Article  CAS  PubMed  Google Scholar 

  16. Ooi YC, Dagi TF, Maltenfort M et al (2012) Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery 71:692–702

    Article  PubMed  Google Scholar 

  17. Haga KK, McClymont KL, Clarke S et al (2011) The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: a systematic review and meta-analysis. J Cardiothorac Surg 6:3

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hua J, Chen G, Li H et al (2012) Intensive intraoperative insulin therapy versus conventional insulin therapy during cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 26:829–834

    Article  CAS  PubMed  Google Scholar 

  19. Bhamidipati CM, LaPar DJ, Stukenborg GJ et al (2011) Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 141:543–551

    Article  PubMed  Google Scholar 

  20. Umpierrez G, Cardona S, Pasquel F et al (2015) Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care 38:1665–1672

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Krinsley JS, Meyfroidt G, van den Berghe G et al (2012) The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care 15:151–160

    Article  CAS  PubMed  Google Scholar 

  22. Brange J, Langkjoer L (1993) Insulin structure and stability. Pharm Biotechnol 5:315–350

    Article  CAS  PubMed  Google Scholar 

  23. Welsh M, Scherberg N, Gilmore R et al (1986) Translational control of insulin biosynthesis. Evidence for regulation of elongation, initiation and signal-recognition-particle-mediated translational arrest by glucose. Biochem J 235:459–467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Wilden PA, Kahn CR, Siddle K et al (1992) Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J Biol Chem 267:16660

    CAS  PubMed  Google Scholar 

  25. Moghissi ES, Korytkowski MT, DiNardo M et al (2009) American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:1119–1131

    Google Scholar 

  26. Ahmed Z, Lockhart CH, Weiner M (2005) Advances in diabetic management: implications for anesthesia. Anesth Analg 100:666–669

    Article  PubMed  Google Scholar 

  27. Mazer M, Chen E (2009) Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis. Ann Emerg Med 53:259–263

    Article  PubMed  Google Scholar 

  28. Joshi GP, Chung F, Vann MA et al (2010) Society for Ambulatory Anesthesia. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg 111:1378–1387

    Google Scholar 

  29. Qaseem A, Chou R, Humphrey LL, Shekelle P; Clinical Guidelines Committee of the American College of Physicians (2014) Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual 29:95–98

    Google Scholar 

  30. Lazar HL, McDonnell M, Chipkin SR et al (2009) The Society of Thoracic Surgeons Practice Guideline Series: blood glucose management during adult cardiac surgery. Ann Thorac Surg 87:663–669

    Article  PubMed  Google Scholar 

  31. Wilson M, Weinreb J, Hoo GW (2007) Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 30:1005–1011

    Article  CAS  PubMed  Google Scholar 

  32. Kanji S, Buffie J, Hutton B et al (2005) Reliability of point-of care testing for glucose measurement in critically ill adults. Crit Care Med 33:2778–2785

    Article  PubMed  Google Scholar 

  33. Cryer PE, Axelrod L, Grossman AB et al (2009) Endocrine Society. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94: 709–728

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Łukasz J. Krzych MD, PhD .

Editor information

Editors and Affiliations

Summary Table

Summary Table

Clinical summary

Drugs

Indications

Cautions

Side effects

Dosage

Notes

Insulin in intravenous infusion (regular human insulin or short-acting analogue)

Perioperative management of hyperglycaemia in patients with diabetes type 1/2 and excessive intraoperative hyperglycaemia in patients without previous history of diabetes

Severe risk of hypoglycaemia and hypokalaemia

Hypoglycaemia

Initial insulin infusion of 0.5–1 IU/h, then 0.3 IU/h increments or decrements depending on blood glucose level

Target intraoperative blood glucose level is 140–180 mg/dL

Glucose level should be checked directly before surgery and every 1 h during and after the procedure

Hypokalaemia

Minor ambulatory procedures in diabetes type 2 can be performed without IV insulin

[K+] should be verified before and after the procedure

Allergic reactions

In patients with a well-controlled diabetes type 2 treated with diet or oral agents, IV insulin is not obligatory

Weight gain

Lipodystrophy

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Krzych, Ł.J., Wybraniec, M.T. (2017). Role of Insulin in Reducing Mortality in the Perioperative Period. In: Landoni, G., Ruggeri, L., Zangrillo, A. (eds) Reducing Mortality in the Perioperative Period. Springer, Cham. https://doi.org/10.1007/978-3-319-46696-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46696-5_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46695-8

  • Online ISBN: 978-3-319-46696-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics